Details for Patent: 6,987,101
✉ Email this page to a colleague
Summary for Patent: 6,987,101
Title: | Therapeutic gestagens for the treatment of premenstrual dysphoric disorder |
Abstract: | A method for treating premenstrual dysphoric disorder comprises administering a therapeutically effective amount of a gestagen. Optionally, a natural or synthetic estrogen is also administered. In one embodiment, the gestagen and optional estrogen are administered during the luteal phase of the female menstrual cycle, preferably from day 10 to day 28. |
Inventor(s): | Nashed; Norman (Munchen, DE) |
Assignee: | Schering Aktiengesellschaft (Berlin, DE) |
Application Number: | 09/619,493 |
Patent Claim Types: see list of patent claims | Use; Delivery; |
Drugs Protected by US Patent 6,987,101
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 6,987,101
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Germany | 196 54 609 | Dec 20, 1996 |
International Family Members for US Patent 6,987,101
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 5981098 | ⤷ Try a Trial | |||
Germany | 19654609 | ⤷ Try a Trial | |||
World Intellectual Property Organization (WIPO) | 9827929 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |